scholarly article | Q13442814 |
P2093 | author name string | Stephan J L Bakker | |
Dick de Zeeuw | |||
Paul E de Jong | |||
Meguid El Nahas | |||
Aminu K Bello | |||
Ronald T Gansevoort | |||
Auke H Brantsma | |||
P433 | issue | 6 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 1619-1627 | |
P577 | publication date | 2007-03-14 | |
P1433 | published in | Nephrology Dialysis Transplantation | Q15710302 |
P1476 | title | Impact of weight change on albuminuria in the general population | |
P478 | volume | 22 |
Q34782969 | Assessment of the relationship of hepatic enzymes with obesity and insulin resistance in adults in saudi arabia |
Q44451538 | Association of body mass index with glomerular filtration rate in Japanese: a cross-sectional study in work-site population. |
Q37743148 | Cardio-Kidney-Damage: a unifying concept |
Q43721013 | Diabetic kidney disease. |
Q87586781 | Do diabetic kidneys deserve a lifestyle change? |
Q44896182 | Early improvement in albuminuria in non-diabetic patients after Roux-en-Y bariatric surgery |
Q38149111 | Effects of weight loss on renal function in obese CKD patients: a systematic review |
Q46942469 | Evaluation of renal function and proteinuria based on mass health examinations in young Japanese obese adults |
Q84978295 | Evidence-based practice guideline for the treatment of CKD |
Q24194514 | HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis |
Q24241472 | HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis |
Q46006386 | High variability of albuminuria in nondiabetic population: the Takahata Study. |
Q57718011 | Implications for kidney disease in obese children and adolescents |
Q42954931 | Independent influence of dietary protein on markers of kidney function and disease in obesity |
Q34138280 | Is the presence of microalbuminuria a relevant marker of kidney disease? |
Q46842364 | Lowering the threshold for defining microalbuminuria: effects of a lifestyle-metformin intervention in obese "normoalbuminuric" non-diabetic subjects |
Q33592804 | Morbidity and mortality associated with obesity |
Q37161462 | New aspects of the relationship among hypertension, obesity, and the kidneys |
Q36865845 | Overweight, obesity, and the development of stage 3 CKD: the Framingham Heart Study |
Q43254390 | Predictors of the early impairment of renal disease in human obesity |
Q36309045 | Prevalence of chronic kidney disease and risk factors for its progression: A cross-sectional comparison of Indians living in Indian versus U.S. cities |
Q24564811 | Renal effects of dapagliflozin in patients with type 2 diabetes |
Q37078053 | Reversibility of albuminuria and continuous positive airway pressure compliance in patients of obstructive sleep apnea syndrome |
Q37205071 | The association of chronic kidney disease and waist circumference and waist-to-height ratio in Chinese urban adults |
Q38826073 | The potential and pitfalls of GLP-1 receptor agonists for renal protection in type 2 diabetes. |
Q37640916 | Weight loss and proteinuria: systematic review of clinical trials and comparative cohorts. |
Q47262363 | Weight loss independently predicts urinary albumin excretion normalization in morbidly obese type 2 diabetic patients undergoing bariatric surgery |